Thor Advisors’s Medtronic MDT Stock Holding History

Thor Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,802	Closed	-$739K	–	158
2019 Q3	$739K	Buy	+6,802	New	+$710K	0.84%	56

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Thor Advisors's MDT Position: Q4 2019 in Review

Thor Advisors sold out of Medtronic (MDT) in Q4 2019, closing a stake of 6,802 shares — an estimated $739K sold.

Thor Advisors first reported a position in MDT in Q3 2019 and held it in 1 quarter. The position peaked at $739K in Q3 2019. 1,820 funds tracked by Wall St. Rank hold MDT as of Q4 2019.

Thor Advisors reported no remaining Medtronic position as of Q4 2019 after selling out during the quarter.
Thor Advisors sold 6,802 Medtronic shares in Q4 2019, an estimated $739K.
Thor Advisors first reported a position in Medtronic in Q3 2019 and held it in 1 quarter.
Thor Advisors's Medtronic position peaked at $739K in Q3 2019.
1,820 funds tracked by Wall St. Rank held Medtronic as of Q4 2019.

Based on Thor Advisors's 13F filing for Q4 2019, filed 18 Feb 2020.